CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

A study published in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that ...

Rothamsted Research’s GM gene-edited low acrylamide wheat has hit problems. An article in Euro News reports that the ...

drawing acclaim for creativity and scientific rigor. The highlight of the day, held at GAU’s auditorium, featured a keynote address by Prof Tofazzal Islam, titled “From DNA to Genome Editing: A ...

The first FA Cup fixtures to take place at Wembley Stadium in 2024/25 have been set, with four teams still in contention to win England’s most high-profile cup competition following the draw for ...

In the latest market close, CRISPR Therapeutics AG (CRSP) reached $39.11, with a +1.48% movement compared to the previous day. This move lagged the S&P 500's daily gain of 2.03%. At the same time ...

killing at least 12 people in its deadliest assault on the Ukrainian capital since July and drawing a rare rebuke of Moscow from U.S. President Donald Trump just as peace efforts were coming to a ...

Arsenal XI: Raya(GK), Timber, Lewis-Skelly, Saliba, Kiwior, Partey, Rice, Odegaard, Sterling, Martinelli, Trossard. Crystal Palace XI: Henderson (GK), Lerma, Lacroix ...